OrganiGram (NASDAQ: OGI) — Perfil da empresa, notícias e dados financeiros
OrganiGram is a Canadian cannabis company focusing on high-quality medical and recreational products, with state-of-the-art facilities.
OrganiGram
OrganiGram (TSX:OGI), (NASDAQ:OGI) is a Canadian company specializing in the production and sale of high-quality, medical and recreational cannabis. The brand is well-known for its focus on innovation, quality control, and patient and customer care. OrganiGram operates out of Moncton, New Brunswick, where it runs a state-of-the-art indoor facility designed to produce consistent, high-quality cannabis. The company is involved in various projects aimed at cannabis product development, including advanced genetics research, novel cultivation techniques, and the creation of new product formulations. OrganiGram's objectives center around expanding its market share in Canada, exploring international markets, and continuing to innovate within the cannabis industry to meet the evolving needs and preferences of its customers.
Resumo
Operações
Produtos e/ou serviços de OrganiGram
- Edison Cannabis Co., offering premium crafted cannabis products for discerning users, emphasizing innovation and quality.
- Trailblazer, a value-oriented brand providing high-quality, affordable cannabis formats including pre-rolls and vape cartridges.
- Ankr Organics, catering to consumers seeking organic, high-grade cannabis with a focus on sustainable and environmentally friendly practices.
- SHRED, popular for its high-quality, finely milled, ready-to-roll cannabis flower, appealing to consumers looking for convenience.
- Monjour, a wellness brand offering CBD products aimed at health-conscious consumers seeking the therapeutic benefits of CBD without psychoactive effects.
- Edison RE:MIX, innovative cannabis-infused powders providing a discreet and convenient way to consume cannabis, easily mixed into any beverage.
equipe executiva do OrganiGram
- Peter L. AmiraultExecutive Chairman
- Greg GuyattChief Financial Officer
- Helen MartinChief Legal Officer & Corporate Secretary
- Timothy EmbergPresident of Organigram Canada
- James H. YamanakaCEO & Director
- Adrian FrenzelGlobal Chief Operating Officer
- Max SchwartzDirector of Investor Relations
- Bradley GunterSenior Vice President of Sales
- Valerie RotherChief People Officer
- Megan Amber McCraeSenior VP of Corporate Strategy & International Growth
Últimas notícias sobre a OrganiGram
Organigram targets $10 million in cost savings
United StatesOrganigram Global delivers $145.1 million third-quarter revenue
United StatesOrganigram revenue dips 9% to $59.8M, German acquisition set to add €100M annually
CryptoOrganigram finalizes acquisition of Sanity Group to secure European market leadership
United StatesOrganigram shareholders overwhelmingly approve Sanity Group acquisition
United StatesOrganigram revenue surges 49% as new CEO James Yamanaka takes the helm
United States
Principais indicadores financeiros
Resultados divulgados pela OrganiGram, em CAD.
- Cap. de mercado
- 135,4 mi
- Receita (TTM)
- 309,2 mi
- P/L
- 2.2
- LPA (diluído, TTM)
- 0.4
- Dividend yield
- —
- Margem de lucro
- 28.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 186,1 mi | -63,4 mi | -17,8 mi | |
| 159,8 mi | -34,8 mi | -45,4 mi | |
| 149,2 mi | -242,7 mi | -229,5 mi | |
| 145,8 mi | -38,8 mi | -14,3 mi |